1. Home
  2. PLSM vs FEMY Comparison

PLSM vs FEMY Comparison

Compare PLSM & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulsenmore Ltd. Ordinary Shares

PLSM

Pulsenmore Ltd. Ordinary Shares

HOLD

Current Price

$1.40

Market Cap

11.6M

Sector

Health Care

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

SELL

Current Price

$1.22

Market Cap

11.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PLSM
FEMY
Founded
2014
2004
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
11.5M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
PLSM
FEMY
Price
$1.40
$1.22
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $14.75
AVG Volume (30 Days)
12.6K
★ 104.8K
Earning Date
08-31-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.71
EPS
★ N/A
N/A
Revenue
N/A
★ $2,293,313.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$294.61
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 40.77
52 Week Low
$1.27
$0.29
52 Week High
$12.97
$6.29

Technical Indicators

Market Signals
Indicator
PLSM
FEMY
Relative Strength Index (RSI) 28.23 36.99
Support Level N/A $0.33
Resistance Level $2.64 $1.55
Average True Range (ATR) 0.12 0.14
MACD 0.00 0.01
Stochastic Oscillator 4.65 36.46

Price Performance

Historical Comparison
PLSM
FEMY

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: